ARCHIVES

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

This article is from The Cancer Letter archive.

Vol. 06 No. 08 | February 22, 1980

Download PDF Visit The Full Archive

Related Articles

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

January 23, 1976

Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor.

February 4, 2000

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

Two Studies Demonstrate Molecule Blocking Cell Damage

August 26, 2011

Two New Modalities Promising For Relapsed/Refractory NHL

January 28, 2005